123 related articles for article (PubMed ID: 2676648)
21. Clinical evaluation of tenoxicam in osteoarthrosis, rheumatoid arthritis and ankylosing spondylitis.
Standel W; Josenhants G
Eur J Rheumatol Inflamm; 1985; 8(1):28-38. PubMed ID: 3915885
[TBL] [Abstract][Full Text] [Related]
22. [A new non-steroidal anti-inflammatory drug pirprofen (rengasil) in the treatment of rheumatoid arthritis and osteoarthrosis].
Sigidin IaA; Pokryshkin VI
Ter Arkh; 1987; 59(4):73-6. PubMed ID: 2954253
[TBL] [Abstract][Full Text] [Related]
23. [Piroxicam in the treatment of rheumatoid arthritis].
Murav'ev IuV; Mamistova AI; Sigidin IaA
Ter Arkh; 1988; 60(4):128-30. PubMed ID: 3293252
[TBL] [Abstract][Full Text] [Related]
24. [Steady-state plasma levels of piroxicam of 4 different origins and relation to clinical effects in the treatment of rheumatoid arthritis].
Pavelka K; Pavelka K; Pelísková Z; Macek J; Lichý A; Trnavský K
Cas Lek Cesk; 1988 Jul; 127(29):905-8. PubMed ID: 3048694
[No Abstract] [Full Text] [Related]
25. Double-blind controlled clinical trial of oral S-adenosylmethionine versus piroxicam in knee osteoarthritis.
Maccagno A; Di Giorgio EE; Caston OL; Sagasta CL
Am J Med; 1987 Nov; 83(5A):72-7. PubMed ID: 3318443
[TBL] [Abstract][Full Text] [Related]
26. Long-term study with Ro 12-0068 (tenoxicam) in the treatment of rheumatoid arthritis.
Mathias Filho AP; Sidi A
Eur J Rheumatol Inflamm; 1985; 8(1):3-8. PubMed ID: 3915886
[TBL] [Abstract][Full Text] [Related]
27. A comparison of severe gastric damage as a result of pirprofen and naproxen treatment in rheumatoid arthritis: a controlled endoscopic study.
Montrone F; Petrillo M; Caruso I; Bianchi Porro G
J Intern Med; 1994 Aug; 236(2):153-9. PubMed ID: 8046314
[TBL] [Abstract][Full Text] [Related]
28. Piroxicam versus naproxen in rheumatoid arthritis: a double-blind, cross-over study.
Larsen A
Int J Clin Pharmacol Res; 1985; 5(1):17-23. PubMed ID: 3888863
[TBL] [Abstract][Full Text] [Related]
29. Piroxicam-beta-cyclodextrin: effects on gastrointestinal blood loss and gastric mucosal appearance in healthy men.
Warrington S; Debbas N; Farthing M; Horton M; Umile A
Int J Tissue React; 1991; 13(5):243-8. PubMed ID: 1806546
[TBL] [Abstract][Full Text] [Related]
30. A double blind cross-over comparison of piroxicam and indomethacin in the treatment of rheumatoid arthritis.
Davies J; Dixon AS; Ring EF
Eur J Rheumatol Inflamm; 1981; 4(3):314-7. PubMed ID: 6242952
[No Abstract] [Full Text] [Related]
31. Therapeutic activity, clinical and gastric tolerance of 20mg daily dose of droxicam in comparison with piroxicam in patients with degenerative joint disease.
Schüetz E; Sánchez J; García-Barbal J; Sarti JF; Reuter C; Harrison FJ
Eur J Rheumatol Inflamm; 1991; 11(4):21-8. PubMed ID: 1365486
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the efficacy and safety of etodolac and piroxicam in patients with rheumatoid arthritis. Etodolac Study 326 Rheumatoid Arthritis Investigators Group.
Lightfoot R
J Rheumatol Suppl; 1997 Feb; 47():10-6. PubMed ID: 9035015
[TBL] [Abstract][Full Text] [Related]
33. Multicenter double-blind randomized clinical trial of imidazole salicylate versus ibuprofen in patients with rheumatoid arthritis.
DiPerri T; Auteri A; Fumagalli M; Gandini R; Giordano A; Giordano M; Scaricabarozzi I; Vaiani G; Vatti M
Int J Clin Pharmacol Ther Toxicol; 1987 Aug; 25(8):443-7. PubMed ID: 3308719
[TBL] [Abstract][Full Text] [Related]
34. [Clinical trails of piroxicam suppositories in the therapy of rheumatoid arthritis].
Iwata H; Nakajima M; Nobenaga T
Ryumachi; 1987 Apr; 27(2):147-55. PubMed ID: 3317919
[No Abstract] [Full Text] [Related]
35. Long-term treatment with tenoxicam in rheumatoid arthritis.
Orozco-Alcalá JJ; Barrera-Tenorio EF
Eur J Rheumatol Inflamm; 1987; 9(2):118-21. PubMed ID: 3329102
[No Abstract] [Full Text] [Related]
36. Gastroduodenal lesions associated with two different piroxicam formulations. An endoscopic comparison.
Aabakken L; Olaussen B; Mowinckel P; Osnes M
Scand J Gastroenterol; 1992 Dec; 27(12):1049-54. PubMed ID: 1475622
[TBL] [Abstract][Full Text] [Related]
37. Double-blind crossover comparison of piroxicam and indomethacin in rheumatoid arthritis.
Domljan Z; Durrigl T
Eur J Rheumatol Inflamm; 1983; 6(3):291-6. PubMed ID: 6391934
[TBL] [Abstract][Full Text] [Related]
38. [Protective effect of ranitidine in the stomach and duodenum against piroxicam. An endoscopy controlled double-blind study].
Müller P; Simon B
Arzneimittelforschung; 1992 Dec; 42(12):1492-4. PubMed ID: 1288514
[TBL] [Abstract][Full Text] [Related]
39. Non-steroidal anti-inflammatory drug-induced gastropathy: a comparative endoscopic and histopathological evaluation of the effects of tenoxicam and diclofenac.
al-Quorain AA; Satti MB; Marwah S; al-Nahdi M; al-Habdan I
J Int Med Res; 1993; 21(2):89-97. PubMed ID: 8243794
[TBL] [Abstract][Full Text] [Related]
40. Tenoxicam, a new non-steroidal anti-inflammatory drug in the prolonged treatment of rheumatoid arthritis.
Gentiletti AA
Eur J Rheumatol Inflamm; 1987; 9(2):91-4. PubMed ID: 3329116
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
